Physician profile
Marino Torres
NPI 1093777609
$2,096.93
in general payments reported to CMS, 2019-2025
11 companies · $72.10 in 2025
The $72.10 reported for 2025 was more than what a typical Pediatric Emergency Medicine (Pediatrics) provider received nationally (typical 2025 total: $53.43).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $758 · 2020: $86.60 · 2021: $229 · 2022: $192 · 2023: $582 · 2024: $178 · 2025: $72.10.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $832.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $832.25 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Glaxosmithkline, LLC. | $801.47 | 2019-2024 | Bexsero, Pediarix, Rotarix |
| Pfizer INC. | $507.79 | 2019-2024 | |
| Cumberland Pharmaceuticals, INC. | $233.53 | 2019-2021 | |
| Amgen INC. | $161.10 | 2023-2024 | Repatha |
| Sanofi Pasteur INC. | $127.32 | 2019-2024 | |
| Merck Sharp & Dohme LLC | $92.67 | 2021-2024 | Vaxneuvance, Gardasil 9, Vaxelis |
| Seqirus USA INC | $65.05 | 2021-2024 | Flucelvax, Flucelvax Quadrivalent |
| Phadia US INC. | $35.90 | 2019-2024 | Immunocap |
| Abbvie INC. | $27.98 | 2025 | |
| Lnhc, INC | $22.55 | 2025 | Zelsuvmi |
| Ars Pharmaceuticals Operations, INC. | $21.57 | 2025 | Neffy |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Marino Torres listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.